Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C

被引:30
作者
Miura, Mika [1 ]
Maekawa, Shinya [1 ]
Kadokura, Makoto [1 ]
Sueki, Ryota [1 ]
Komase, Kazuki [1 ]
Shindo, Hiroko [1 ]
Ohmori, Takako [1 ]
Kanayama, Asuka [1 ]
Shindo, Kuniaki [1 ]
Amemiya, Fumitake [1 ]
Nakayama, Yasuhiro [1 ]
Kitamura, Takatoshi [1 ]
Uetake, Tomoyoshi [1 ]
Inoue, Taisuke [1 ]
Sakamoto, Minoru [1 ]
Okada, Shunichi [1 ]
Enomoto, Nobuyuki [1 ]
机构
[1] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi 4093898, Japan
关键词
HCV; HCC; Core; IL28B; VIRUS GENOTYPE 1B; CORE PROTEIN; COMBINATION THERAPY; IMPORTANT PREDICTOR; RIBAVIRIN THERAPY; GENETIC-VARIATION; OXIDATIVE STRESS; LIVER-DISEASE; INTERFERON; REGION;
D O I
10.1007/s12072-011-9307-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims The association between hepatitis C virus (HCV) sequences with interleukin 28B (IL28B) single-nucleotide polymorphism (SNP) in the development of hepatocellular carcinoma (HCC) has not been well clarified. Methods Complete HCV open-reading frame sequences were determined in 20 patients developing HCC and 23 non-HCC patients with HCV-1b infection in two distant time points. An additional 230 patients were studied cross-sectionally for core and NS5A sequences with HCC development. Among them, 98 patients with available samples were investigated for changes in viral core sequences over time. Finally, IL28B SNPs and HCC development were investigated in 228 patients. Results During observation period (HCC for 10.8 years, and non-HCC for 11.1 years), changes in core a. a. 70 and three amino acid positions in NS5A were characteristics of the patients developing HCC. In 230 patients, Q (glutamine) or H (histidine) to R (arginine) ratio at core a. a. 70 was significantly higher in the HCC group (HCC group 43: 22 vs. non-HCC group 66: 99, p = 0.001). A change in core R70Q was observed over time in 11 patients associated with a decrease in platelets (p = 0.005) and albumin (p = 0.005), while a Q70R change was observed in 4 patients without associated changes in platelets (nonsignificant) and albumin (nonsignificant). IL28B SNP showed significant correlation with the core a. a. 70 residue. There was no evident link between IL28B SNPs and the occurrence of HCC. Conclusions Hepatitis C virus core a. a. 70 residue is associated with liver disease progression and is independent factor for HCC development in genotype-1b infection. IL28B SNPs are related to core a. a. 70 residue, but not to HCC. The functional relevance of core a. a. 70 residue in hepatitis C pathogenesis should be further investigated.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 25 条
[1]   Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy [J].
Akuta, N ;
Suzuki, F ;
Sezaki, H ;
Suzuki, Y ;
Hosaka, T ;
Someya, T ;
Kobayashi, M ;
Saitoh, S ;
Watahiki, S ;
Sato, J ;
Matsuda, M ;
Kobayashi, M ;
Arase, Y ;
Ikeda, K ;
Kumada, H .
INTERVIROLOGY, 2005, 48 (06) :372-380
[2]   Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (08) :1354-1362
[3]   Amino acid substitutions in the hepatitis c virus core region are the important predictor of hepatocarcinogenesis [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumadal, Hiromitsu .
HEPATOLOGY, 2007, 46 (05) :1357-1364
[4]   Hepatitis C virus-induced hepatocarcinogenesis [J].
Bartosch, Birke ;
Thimme, Robert ;
Blum, Hubert E. ;
Zoulim, Fabien .
JOURNAL OF HEPATOLOGY, 2009, 51 (04) :810-820
[5]   Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy [J].
El-Shamy, Ahmed ;
Nagano-Fujii, Motoko ;
Sasase, Noriko ;
Imoto, Susumu ;
Kim, Soo-Ryang ;
Hotta, Hak .
HEPATOLOGY, 2008, 48 (01) :38-47
[6]   Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection [J].
Enomoto, N ;
Sakuma, I ;
Asahina, Y ;
Kurosaki, M ;
Murakami, T ;
Yamamoto, C ;
Ogura, Y ;
Izumi, N ;
Marumo, F ;
Sato, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) :77-81
[7]   Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease [J].
Franco, S ;
Giménez-Barcons, M ;
Puig-Basagoiti, F ;
Furcic, I ;
Sánchez-Tapias, JM ;
Rodés, J ;
Sáiz, JC .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) :195-204
[8]   Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C [J].
Fukuhara, Takasuke ;
Taketomi, Akinobu ;
Motomura, Takashi ;
Okano, Shinji ;
Ninomiya, Akinori ;
Abe, Takayuki ;
Uchiyama, Hideaki ;
Soejima, Yuji ;
Shirabe, Ken ;
Matsuura, Yoshiharu ;
Maehara, Yoshihiko .
GASTROENTEROLOGY, 2010, 139 (05) :1577-+
[9]   Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].
Ge, Dongliang ;
Fellay, Jacques ;
Thompson, Alexander J. ;
Simon, Jason S. ;
Shianna, Kevin V. ;
Urban, Thomas J. ;
Heinzen, Erin L. ;
Qiu, Ping ;
Bertelsen, Arthur H. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
McHutchison, John G. ;
Goldstein, David B. .
NATURE, 2009, 461 (7262) :399-401
[10]   High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis [J].
Giménez-Barcons, M ;
Franco, S ;
Suárez, Y ;
Forns, X ;
Ampurdanès, S ;
Puig-Basagoiti, F ;
Sánchez-Fueyo, A ;
Barrera, JM ;
Llovet, JM ;
Bruix, J ;
Sánchez-Tapias, JM ;
Rodés, J ;
Saiz, JC .
HEPATOLOGY, 2001, 34 (01) :158-167